P1 · Therapeutic area intelligence
Immunology patent intelligence
Autoimmune, rheumatology, and immunology biologic patents — biosimilar entry timing signals.
- Patents
- 11
Quick answer
11 US pharmaceutical patents in our index match Immunology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.
-
US 12246064
Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate
granted -
US 11884731
Vedolizumab for the treatment of fistulizing Crohn's disease
granted -
US 11622991
Protocol for treatment of lupus nephritis
granted -
US 10286036
Protocol for treatment of lupus nephritis
granted -
US 9687522
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
granted -
US 2017020867
USE OF MASITINIB FOR THE TREATMENT OF CROHN'S DISEASE
granted -
US 9161935
Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy
granted -
US 8889661
Treatment of lupus nephritis using laquinimod
granted -
US 8759302
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
granted -
US 8598203
Treatment of Crohn's disease with laquinimod
granted -
US 8501766
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
granted
Frequently asked questions
How many Immunology patents are indexed?
11 patents match our Immunology classifier (title keywords in USPTO records).
Is this legal or medical advice?
No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.